The Diabetes business unit at Medtronic (NYSE:MDT) could have some exciting offering in the pipeline, company officials say.
After an FDA warning, Medtronic has recalled two of its MiniMed ... having involved the company’s Medfusion 4000 drug infusion pumps. It’s a widespread problem, however. In 2017, the FDA ...
WASHINGTON, D.C. — The U.S. Food and Drug Administration has issued a Class I recall, the most serious type, on Medtronic’s ...
An insulin pump can more closely mimic the way a healthy pancreas works, through a Continuous Subcutaneous Insulin Infusion (CSII), replaces the ... to learn more about insulin pump therapy please ...
BURLINGAME, CA, UNITED STATES, December 27, 2024 /EINPresswire / -- Ambulatory Infusion Pumps market Trends Overview 2024-2031: A new Report by Coherent Market Insights, titled "Ambulatory ...